Comparative efficacy and safety of anti-HGF/MET pathway agents plus chemotherapy versus chemotherapy alone as first-line treatment in advanced gastric cancer: a protocol for a systematic review and meta-analysis
- DOI
- 10.1136/bmjopen-2021-049575
- Published
- 2021-12
- Container
- BMJ Open
- Publisher
- BMJ
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/bmjopen-2021-049575,
title = {Comparative efficacy and safety of anti-HGF/MET pathway agents plus chemotherapy versus chemotherapy alone as first-line treatment in advanced gastric cancer: a protocol for a systematic review and meta-analysis},
author = {Zhiyuan Jiang and Zhaolun Cai and Qin Ma and Chaoyong Shen and Yuan Yin and Xiaonan Yin and Chunyu Liu and Chen Chang and Zhou Zhao and Mingchun Mu and Bo Zhang},
year = {2021},
journal = {BMJ Open},
doi = {10.1136/bmjopen-2021-049575},
url = {https://doi.org/10.1136/bmjopen-2021-049575}
}RIS
TY - JOUR TI - Comparative efficacy and safety of anti-HGF/MET pathway agents plus chemotherapy versus chemotherapy alone as first-line treatment in advanced gastric cancer: a protocol for a systematic review and meta-analysis AU - Zhiyuan Jiang AU - Zhaolun Cai AU - Qin Ma AU - Chaoyong Shen AU - Yuan Yin AU - Xiaonan Yin AU - Chunyu Liu AU - Chen Chang AU - Zhou Zhao AU - Mingchun Mu AU - Bo Zhang PY - 2021 JO - BMJ Open DO - 10.1136/bmjopen-2021-049575 UR - https://doi.org/10.1136/bmjopen-2021-049575 ER -
APA
Jiang, Z., Cai, Z., Ma, Q., Shen, C., Yin, Y., Yin, X., Liu, C., Chang, C., Zhao, Z., Mu, M., & Zhang, B. (2021). Comparative efficacy and safety of anti-HGF/MET pathway agents plus chemotherapy versus chemotherapy alone as first-line treatment in advanced gastric cancer: a protocol for a systematic review and meta-analysis. BMJ Open. https://doi.org/10.1136/bmjopen-2021-049575
Source records
- crossref · retrieved 2026-09-25T14:40:39.313Z